手法を比較
選択した手法を並べて確認できます。異なる行はハイライト表示されます。
| RMI: Rivermead Mobility Index× | EDSS: Kurtzke Expanded Disability Status Scale (拡張身体機能障害尺度)× | |
|---|---|---|
| 分野 | 神経学 | 神経学 |
| 系統 | Process / pipeline | Process / pipeline |
| 提唱年≠ | 1991 | 1983 |
| 提唱者≠ | Frank Collen, Derick Wade, and Rivermead Rehabilitation Centre | John F. Kurtzke |
| 種類≠ | Clinician-observed performance test | Clinician-rated |
| 原典≠ | Collen, F. M., Wade, D. T., Robb, G. F., Bradshaw, C. M. (1991). The Rivermead Mobility Index: A further development of the Rivermead Motor Assessment. International Disability Studies, 13(2), 50-54. DOI ↗ | Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology, 33(11), 1444-1452. DOI ↗ |
| 別名 | Rivermead Mobility Index | Expanded Disability Status Scale |
| 関連≠ | 5 | 4 |
| 概要≠ | The Rivermead Mobility Index (RMI) is a brief, clinician-observed performance test of basic mobility abilities developed for assessing stroke and neurological rehabilitation outcomes. Published in 1991 by Frank Collen and colleagues at Rivermead Rehabilitation Centre (Oxford, UK), the 15-item index measures bed mobility, sitting/standing balance, transfers, and ambulation. The RMI is widely used in stroke units and rehabilitation settings to track functional recovery and predict discharge outcomes. | The EDSS is the most widely used clinical disability rating scale in multiple sclerosis research and practice. Developed by John Kurtzke in 1983, it provides a 0-10 ordinal scale capturing disease severity across eight neurological functional systems and functional status. The EDSS remains the primary endpoint in MS clinical trials and longitudinal cohort studies, with decades of prognostic and comparative data worldwide. |
| ScholarGateデータセット ↗ |
|
|